APOE alleles also influence when a patient is likely to receive an AD diagnosis, with those who are homozygous for ɛ4 being diagnosed at an average age of 68, those who are heterozygous for ɛ4 diagnosed at an average age of 76, and non-carriers diagnosed at an average age of 84 [59]. The gene discussed is APOE; the disease is Alzheimer disease.